Figure 4
From: Determining KLF14 tertiary structure and diagnostic significance in brain cancer progression
Expression of TPD52, PKCε, KLF14 and miRNA124 in male and female patients. (A) Expression of TPD52 in male and female patients compared to healthy male and female controls, respectively; (B) Expression of PKCε in male and female patients compared to healthy male and female controls, respectively; (C) Expression of KLF14 in male and female patients compared to healthy male and female controls, respectively; (D) Expression of miRNA 124 in male and female patients compared to healthy male and female control, respectivelys. There is significant difference of PKCε, TPD52, miRNA124, and KLF14 between male and female patients group and healthy control (P = 0.0003, P = 0.0002, P < 0.0001, P = 0.0027 respectively). Representative data were presented as mean ± SEM of triplicate experiments. Statistical significance was measured by one-way ANOVA (****P < 0.0001, ***P < 0.01, **P < 0.05).
